118 related articles for article (PubMed ID: 23201219)
1. Ocular experimental leishmaniasis in C57BL/10 and BALB/c mice induced by Leishmania amazonensis infection.
Calabrese KS; Silva LS; Hardoim DJ; Souza CS; Abreu-Silva AL
Exp Parasitol; 2013 Feb; 133(2):156-61. PubMed ID: 23201219
[TBL] [Abstract][Full Text] [Related]
2. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.
Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I
Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
4. Expression of infection-related genes in parasites and host during murine experimental infection with Leishmania (Leishmania) amazonensis.
Pereira BA; Britto C; Alves CR
Microb Pathog; 2012 Feb; 52(2):101-8. PubMed ID: 22178713
[TBL] [Abstract][Full Text] [Related]
5. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis.
Barral-Netto M; Cardoso SA; Barral A
Acta Trop; 1987 Mar; 44(1):5-11. PubMed ID: 2884839
[TBL] [Abstract][Full Text] [Related]
6. Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice.
de Oliveira Cardoso F; de Souza Cda S; Mendes VG; Abreu-Silva AL; Gonçalves da Costa SC; Calabrese KS
J Infect Dis; 2010 Jun; 201(12):1933-40. PubMed ID: 20462353
[TBL] [Abstract][Full Text] [Related]
7. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
8. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
9. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
Hernández-Chinea C
Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
[TBL] [Abstract][Full Text] [Related]
10. In vivo near-infrared fluorescence imaging of Leishmania amazonensis expressing infrared fluorescence protein (iRFP) for real-time monitoring of cutaneous leishmaniasis in mice.
Oliveira JC; da Silva AC; Oliveira RA; Pereira VR; Gil LH
J Microbiol Methods; 2016 Nov; 130():189-195. PubMed ID: 27498229
[TBL] [Abstract][Full Text] [Related]
11. Leishmania (L.) amazonensis: fusion between parasitophorous vacuoles in infected bone-marrow derived mouse macrophages.
Real F; Pouchelet M; Rabinovitch M
Exp Parasitol; 2008 May; 119(1):15-23. PubMed ID: 18346736
[TBL] [Abstract][Full Text] [Related]
12. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.
Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF
Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949
[TBL] [Abstract][Full Text] [Related]
13. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected.
Abreu-Silva AL; Calabrese KS; Cupolilo SM; Cardoso FO; Souza CS; Gonçalves da Costa SC
Vet Parasitol; 2004 May; 121(3-4):179-87. PubMed ID: 15135858
[TBL] [Abstract][Full Text] [Related]
14. Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana.
Aguilar Torrentera F; Lambot MA; Laman JD; Van Meurs M; Kiss R; Noël JC; Carlier Y
Am J Trop Med Hyg; 2002 Mar; 66(3):273-9. PubMed ID: 12139220
[TBL] [Abstract][Full Text] [Related]
15. Saliva of laboratory-reared Lutzomyia longipalpis exacerbates Leishmania (Leishmania) amazonensis infection more potently than saliva of wild-caught Lutzomyia longipalpis.
Laurenti MD; Silveira VM; Secundino NF; Corbett CE; Pimenta PP
Parasitol Int; 2009 Sep; 58(3):220-6. PubMed ID: 19454323
[TBL] [Abstract][Full Text] [Related]
16. Leishmania (Leishmania) amazonensis infection in mice treated with FTY720.
Lopes CT; de Paula DM; Cury PM; Valero-Lapchik VB; Bueno V
Transplant Proc; 2010 Mar; 42(2):578-81. PubMed ID: 20304196
[TBL] [Abstract][Full Text] [Related]
17. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
[TBL] [Abstract][Full Text] [Related]
18. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis].
Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L
Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193
[TBL] [Abstract][Full Text] [Related]
19. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum.
Rosypal AC; Zajac AM; Troy GC; Lindsay DS
Vet Parasitol; 2005 Jun; 130(1-2):19-27. PubMed ID: 15893066
[TBL] [Abstract][Full Text] [Related]
20. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice.
Almeida RP; Barral-Netto M; De Jesus AM; De Freitas LA; Carvalho EM; Barral A
Am J Trop Med Hyg; 1996 Feb; 54(2):178-84. PubMed ID: 8619444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
